High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy.

High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy. — المؤلف: Falchi, Lorenzo — Journal of hematology & oncology 20171127

المؤلف
Falchi, Lorenzo
النشر
Journal of hematology & oncology 20171127
الوصف
132 p.
الموضوعات
Antibodies, Monoclonal؛ Antibodies, Monoclonal, Humanized؛ Antimetabolites, Antineoplastic؛ Antineoplastic Agents, Immunological؛ Azacitidine؛ Cell Cycle Checkpoints؛ DNA Methylation؛ Hodgkin Disease